Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 4
1970 7
1971 21
1972 14
1973 15
1974 19
1975 29
1976 29
1977 37
1978 30
1979 38
1980 33
1981 38
1982 29
1983 54
1984 37
1985 50
1986 70
1987 63
1988 59
1989 70
1990 91
1991 80
1992 93
1993 86
1994 104
1995 139
1996 116
1997 124
1998 150
1999 153
2000 118
2001 111
2002 125
2003 118
2004 99
2005 142
2006 127
2007 125
2008 112
2009 101
2010 88
2011 101
2012 87
2013 100
2014 92
2015 81
2016 80
2017 67
2018 69
2019 50
2020 45
2021 43
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

3,750 results
Results by year
Filters applied: . Clear all
Page 1
The effect of inhaled salbutamol on the outcomes of transient tachypnea of the newborn.
Malakian A, Dehdashtian M, Aramesh MR, Aletayeb MH, Heidari S. Malakian A, et al. J Chin Med Assoc. 2018 Nov;81(11):990-997. doi: 10.1016/j.jcma.2018.01.015. Epub 2018 Aug 18. J Chin Med Assoc. 2018. PMID: 30131296 Free article. Clinical Trial.
A delay in lung fluid absorption in neonates disrupts the transition from intrauterine to extrauterine life. Use of beta-adrenergic antagonists, such as salbutamol, accelerates lung fluid clearance. The current study aimed to evaluate the effect of inhaled salbutamol
A delay in lung fluid absorption in neonates disrupts the transition from intrauterine to extrauterine life. Use of beta-adrenergic antagoni …
The Clinical Practice and Best Aerosol Delivery Location in Intubated and Mechanically Ventilated Patients: A Randomized Clinical Trial.
Zhang C, Mi J, Zhang Z, Wang X, Zhu Y, Luo X, Gan R, Chen X, Zou Y. Zhang C, et al. Biomed Res Int. 2021 Apr 3;2021:6671671. doi: 10.1155/2021/6671671. eCollection 2021. Biomed Res Int. 2021. PMID: 33884269 Free PMC article. Clinical Trial.
An indirect competitive enzyme-linked immunosorbent assay (ELISA) was used to measure salbutamol drug concentrations in serum and urine. The serum and urine salbutamol concentrations of the three groups were the highest in group B, followed by group C, and the lowes …
An indirect competitive enzyme-linked immunosorbent assay (ELISA) was used to measure salbutamol drug concentrations in serum and uri …
Salbutamol.
Gupta SK, Das S. Gupta SK, et al. J Indian Med Assoc. 1973 Nov 1;61(9):388-92. J Indian Med Assoc. 1973. PMID: 4599204 Clinical Trial. No abstract available.
Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma.
Maier G, Rubino C, Hsu R, Grasela T, Baumgartner RA. Maier G, et al. Pulm Pharmacol Ther. 2007;20(5):534-42. doi: 10.1016/j.pupt.2006.05.003. Epub 2006 May 27. Pulm Pharmacol Ther. 2007. PMID: 16891136 Clinical Trial.
METHODS: The data for this analysis were collected from patients enrolled in a randomized, double-blind, multicenter, placebo- and active-controlled study evaluating the safety and efficacy of levalbuterol in asthmatic children aged 4-11 years. Patients received either …
METHODS: The data for this analysis were collected from patients enrolled in a randomized, double-blind, multicenter, placebo- and active-co …
Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.
Brunetti L, Poiani G, Dhanaliwala F, Poppiti K, Kang H, Suh DC. Brunetti L, et al. Am J Health Syst Pharm. 2015 Jun 15;72(12):1026-35. doi: 10.2146/ajhp140551. Am J Health Syst Pharm. 2015. PMID: 26025994 Clinical Trial.
Hospital length of stay was significantly greater in the levalbuterol group (mean S.D., 8.5 5.2 days versus 6.8 3.6 days with albuterol use; p = 0.040). CONCLUSION: Clinical outcomes were similar with the use of levalbuterol versus albuterol for exacer …
Hospital length of stay was significantly greater in the levalbuterol group (mean S.D., 8.5 5.2 days versus 6.8 3.6 days with albu
Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction.
Arroyo MG, Couëtil LL, Nogradi N, Kamarudin MM, Ivester KM. Arroyo MG, et al. J Vet Intern Med. 2016 Jul;30(4):1333-7. doi: 10.1111/jvim.14320. Epub 2016 Jun 9. J Vet Intern Med. 2016. PMID: 27282625 Free PMC article. Clinical Trial.
Levalbuterol is commercially available and improves pulmonary function of asthmatic patients with a longer duration of effect than albuterol. ...The magnitude of bronchodilatation was not significantly different between the 2 treatments (61.1 and 59.9% decrease in D
Levalbuterol is commercially available and improves pulmonary function of asthmatic patients with a longer duration of effect than
Salmeterol in paediatric asthma.
Byrnes C, Shrewsbury S, Barnes PJ, Bush A. Byrnes C, et al. Thorax. 2000 Sep;55(9):780-4. doi: 10.1136/thorax.55.9.780. Thorax. 2000. PMID: 10950898 Free PMC article. Clinical Trial.
METHODS: The aim of this study was to compare, in a double blind, three way, crossover study, the effects of the addition of salmeterol 50 microg bd, salmeterol 100 microg bd, and salbutamol 200 microg qds in asthmatic children who were symptomatic despite treatment with i …
METHODS: The aim of this study was to compare, in a double blind, three way, crossover study, the effects of the addition of salmeterol 50 m …
Salbutamol in the 1980s. A reappraisal of its clinical efficacy.
Price AH, Clissold SP. Price AH, et al. Drugs. 1989 Jul;38(1):77-122. doi: 10.2165/00003495-198938010-00004. Drugs. 1989. PMID: 2670512 Review.
Salbutamol (albuterol) is a beta 2-selective adrenoceptor agonist which accounts for its pronounced bronchodilatory, cardiac, uterine and metabolic effects. ...Salbutamol is generally well tolerated and any side effects observed are a predictable extension of
Salbutamol (albuterol) is a beta 2-selective adrenoceptor agonist which accounts for its pronounced bronchodilatory, cardiac,
Change in Oxygen Consumption Following Inhalation of Albuterol in Comparison with Levalbuterol in Healthy Adult Volunteers.
Virk MK, Hotz J, Khemani RG, Newth CJ, Ross PA. Virk MK, et al. Lung. 2017 Apr;195(2):233-239. doi: 10.1007/s00408-017-9982-8. Epub 2017 Feb 16. Lung. 2017. PMID: 28210808 Clinical Trial.
Albuterol contains a racemic mixture of two enantiomers. Levalbuterol contains the single R form enantiomer. ...Subjects separately received albuterol (5 mg) and levalbuterol (2.5 mg) aerosolized over 15 min. ...
Albuterol contains a racemic mixture of two enantiomers. Levalbuterol contains the single R form enantiomer. ...Subjects separ
Plant-based formulation for bronchial asthma: a controlled clinical trial to compare its efficacy with oral salbutamol and theophylline.
Murali PM, Rajasekaran S, Krishnarajasekar OR, Perumal T, Nalini K, Lakshmisubramanian S, Deivanayagam CN. Murali PM, et al. Respiration. 2006;73(4):457-63. doi: 10.1159/000089922. Epub 2005 Nov 22. Respiration. 2006. PMID: 16308544 Clinical Trial.
Fifty percent of DCBT4567-Astha-15, 48% of salbutamol, 58% of salbutamol + theophylline and 26% of placebo patients showed the desired 15% improvement in FEV(1). Improved mean FEV(1) values at the end of the trial indicated that the salbutamol - theophylline …
Fifty percent of DCBT4567-Astha-15, 48% of salbutamol, 58% of salbutamol + theophylline and 26% of placebo patients showed the …
3,750 results